Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Dichloromethane → (S)-(5-(((5-chloropyridin-2-yl)amino)methyl)-6-azaspiro[2.5]octan-6-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Dichloromethane | HCID 6344 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | Propylphosphonic anhydride | HCID 111923 | — |
| 반응물 | 5-Methyl-2-(pyrimidin-2-yl)benzoic acid | HCID 44517264 | — |
| 반응물 | (S)-1-Boc-4-oxopiperidine-2-carboxylic acid tert-butylamine salt | HCID 66848353 | — |
| 생성물 | (S)-(5-(((5-chloropyridin-2-yl)amino)methyl)-6-azaspiro[2.5]octan-6-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone | HCID 60169549 | — |
반응 단계
Alternatively Compound 13 was obtained by the following procedure: 5-methyl-2-(pyrimidin-2-yl)benzoic acid (428 mg, 2 mmol; prepared according to WO 2008147518), intermediate 34 (500 mg, 2 mmol) and DIPEA (0.65 ml) were dissolved in DCM (5 ml) at 0° C., then T3P (50% in DCM, 1.5 g) was added. The mixture is stirred at reflux for 8 hours then at RT overnight. The reaction was washed with NaOH 1M and water, dried (Na2SO4) and evaporated. The crude was purified by silica gel column chromatography (DCM to DCM/MeOH=95/05). 180 mg of the desired compound were isolated.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08859608B2 |
| 출처 데이터셋 | uspto-grants-2014_10 |
| ORD ID | ord-b24d643e62b54fb8942e4316b1d777d7 |
| 출처 메모 | uspto-grants-2014_10 |